Skip to main navigation Skip to search Skip to main content

Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial

  • Dana T. Goldberg
  • , Anat Yaskolka Meir
  • , Gal Tsaban
  • , Ehud Rinott
  • , Alon Kaplan
  • , Hila Zelicha
  • , Nora Klöting
  • , Uta Ceglarek
  • , Berend Iserman
  • , Ilan Shelef
  • , Philip Rosen
  • , Matthias Blüher
  • , Michael Stumvoll
  • , Ohad Etzion
  • , Meir J. Stampfer
  • , Frank B. Hu
  • , Iris Shai

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background and Aims: We demonstrated in the randomized 18-month DIRECT PLUS trial (n = 294) that a Mediterranean (MED) diet, supplemented with polyphenol-rich Mankai duckweed, green tea, and walnuts and restricted in red/processed meat, caused substantial intrahepatic fat (IHF%) loss compared with 2 other healthy diets, reducing NAFLD by half, regardless of similar weight loss. Here, we investigated the baseline proteomic profile associated with IHF% and the changes in proteomics associated with IHF% changes induced by lifestyle intervention. Approach and Results: We calculated IHF% by proton magnetic resonance spectroscopy (normal IHF% <5% and abnormal IHF% ≥5%). We assayed baseline and 18-month samples for 95 proteomic biomarkers.Participants (age = 51.3 ± 10.8 y; 89% men; and body mass index = 31.3 ± 3.9 kg/m2) had an 89.8% 18-month retention rate; 83% had eligible follow-up proteomics measurements, and 78% had follow-up proton magnetic resonance spectroscopy. At baseline, 39 candidate proteins were significantly associated with IHF% (false discovery rate <0.05), mostly related to immune function pathways (eg, hydroxyacid oxidase 1). An IHF% prediction based on the DIRECT PLUS by combined model (R 2 = 0.47, root mean square error = 1.05) successfully predicted IHF% (R 2 = 0.53) during testing and was stronger than separately inputting proteins/traditional markers (R 2 = 0.43/0.44). The 18-month lifestyle intervention induced changes in 18 of the 39 candidate proteins, which were significantly associated with IHF% change, with proteins related to metabolism, extracellular matrix remodeling, and immune function pathways. Thrombospondin-2 protein change was higher in the green-MED compared to the MED group, beyond weight and IHF% loss (p = 0.01). Protein principal component analysis revealed differences in the third principal component time distinct interactions across abnormal/normal IHF% trajectory combinations; p < 0.05 for all). Conclusions: Our findings suggest novel proteomic signatures that may indicate MRI-assessed IHF state and changes during lifestyle intervention. Specifically, carbonic anhydrase 5A, hydroxyacid oxidase 1, and thrombospondin-2 protein changes are independently associated with IHF% change, and thrombospondin-2 protein change is greater in the green-MED/high polyphenols diet.

Original languageEnglish
Pages (from-to)198-211
Number of pages14
JournalHepatology
Volume81
Issue number1
DOIs
StatePublished - 1 Jan 2025

ASJC Scopus subject areas

  • Hepatology

Fingerprint

Dive into the research topics of 'Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial'. Together they form a unique fingerprint.

Cite this